BioSpace News Archive

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, reported financial results for the three and twelve months ended December 31, 2020.

NextCure, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, reported fourth quarter and full year 2020 financial results and provided a business update.

Lexicon Pharmaceuticals, Inc., will release its fourth quarter and full-year 2020 financial results on Wednesday, March 10, 2021 after the markets close.

Evoke Pharma, Inc., a specialty pharmaceutical company focused on treatments for gastrointestinal disorders and diseases, announced that the Company is scheduled to release its fourth quarter and full year 2020 financial results on Thursday, March 11, 2021, after the market closes.

Evofem Biosciences, Inc., a commercial stage biopharmaceutical company, reported financial results for the three- and twelve-month periods ended December 31, 2020.

ViewRay, Inc. announced financial results for the fourth quarter and year ended December 31, 2020.

Prometheus Biosciences, Inc., a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease, announced the appointment of commercial veteran Mark Stenhouse as Chief Operating Officer.

Soliton, Inc., a medical device company with a novel and proprietary platform technology, reported financial results for the fourth quarter and full year ended December 31, 2020.

Biofacturing leader Zymergen announced Christine Gorjanc has joined its board of directors to help the company achieve its long term goals.

DURECT Corporation announced financial results for the three months and year ended December 31, 2020 and provided a corporate update.